Jianmin Pharmaceutical Group Co.,Ltd. (SHA:600976)
China
· Delayed Price · Currency is CNY 41.90
-0.03 (-0.07%)
Apr 30, 2025, 3:00 PM CST
SHA:600976 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Jan '21 Jan 1, 2021 | 2015 - 2019 |
| Operating Revenue | 3,427 | 3,505 | 4,190 | 3,623 | 3,292 | 2,445 | Upgrade
|
| Other Revenue | - | - | 23.59 | 17.41 | 7.8 | 11.32 | Upgrade
|
| Revenue | 3,427 | 3,505 | 4,213 | 3,641 | 3,299 | 2,456 | Upgrade
|
| Revenue Growth (YoY) | -17.82% | -16.81% | 15.72% | 10.35% | 34.34% | 9.70% | Upgrade
|
| Cost of Revenue | 1,652 | 1,832 | 2,279 | 2,067 | 1,882 | 1,460 | Upgrade
|
| Gross Profit | 1,775 | 1,673 | 1,934 | 1,574 | 1,417 | 996.15 | Upgrade
|
| Selling, General & Admin | 1,482 | 1,420 | 1,515 | 1,203 | 1,129 | 889.85 | Upgrade
|
| Research & Development | 77.55 | 79.49 | 74.05 | 73.19 | 52.61 | 37.4 | Upgrade
|
| Other Operating Expenses | -25.71 | -28.4 | 29.03 | 24.52 | 22.96 | 14.28 | Upgrade
|
| Operating Expenses | 1,534 | 1,472 | 1,621 | 1,311 | 1,210 | 942.47 | Upgrade
|
| Operating Income | 240.95 | 201.42 | 313.12 | 262.77 | 207.46 | 53.69 | Upgrade
|
| Interest Expense | - | - | -3.7 | -4.81 | -8.71 | -0.55 | Upgrade
|
| Interest & Investment Income | 166.32 | 226.09 | 235.04 | 167.26 | 127.46 | 104.91 | Upgrade
|
| Other Non Operating Income (Expenses) | -63.27 | -61.77 | -7.51 | -21.95 | -4.77 | -0.39 | Upgrade
|
| EBT Excluding Unusual Items | 382.68 | 365.74 | 536.94 | 403.27 | 321.44 | 157.66 | Upgrade
|
| Gain (Loss) on Sale of Investments | 28.02 | 28.4 | 6.18 | -12.11 | -2.46 | -1.6 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.12 | -0.12 | 0.16 | -1.14 | -0.93 | -0.22 | Upgrade
|
| Asset Writedown | -1.4 | -1.4 | -11.39 | -9.61 | -0.09 | -1.38 | Upgrade
|
| Other Unusual Items | - | - | 39.21 | 57.53 | 23.5 | 3.16 | Upgrade
|
| Pretax Income | 409.17 | 392.62 | 571.09 | 437.94 | 341.45 | 157.61 | Upgrade
|
| Income Tax Expense | 30.58 | 24.87 | 47.86 | 31.93 | 35.51 | 8.92 | Upgrade
|
| Earnings From Continuing Operations | 378.59 | 367.75 | 523.23 | 406.01 | 305.94 | 148.69 | Upgrade
|
| Minority Interest in Earnings | -5.76 | -5.57 | -1.78 | 2.07 | -0.68 | -0.9 | Upgrade
|
| Net Income | 372.83 | 362.18 | 521.46 | 408.08 | 305.26 | 147.79 | Upgrade
|
| Net Income to Common | 372.83 | 362.18 | 521.46 | 408.08 | 305.26 | 147.79 | Upgrade
|
| Net Income Growth | -28.50% | -30.55% | 27.78% | 33.68% | 106.55% | 61.53% | Upgrade
|
| Shares Outstanding (Basic) | 152 | 152 | 153 | 152 | 152 | 154 | Upgrade
|
| Shares Outstanding (Diluted) | 152 | 152 | 153 | 152 | 152 | 154 | Upgrade
|
| Shares Change (YoY) | -0.83% | -0.49% | 0.43% | 0.26% | -1.35% | 0.96% | Upgrade
|
| EPS (Basic) | 2.46 | 2.38 | 3.41 | 2.68 | 2.01 | 0.96 | Upgrade
|
| EPS (Diluted) | 2.46 | 2.38 | 3.41 | 2.68 | 2.01 | 0.96 | Upgrade
|
| EPS Growth | -27.89% | -30.20% | 27.24% | 33.33% | 109.38% | 60.00% | Upgrade
|
| Free Cash Flow | 137.19 | 113.98 | 203.89 | 147.9 | 191.77 | 79.96 | Upgrade
|
| Free Cash Flow Per Share | 0.91 | 0.75 | 1.33 | 0.97 | 1.26 | 0.52 | Upgrade
|
| Dividend Per Share | - | - | 1.200 | 1.000 | 0.806 | 0.366 | Upgrade
|
| Dividend Growth | - | - | 20.00% | 24.07% | 120.22% | 83.00% | Upgrade
|
| Gross Margin | 51.79% | 47.73% | 45.91% | 43.23% | 42.96% | 40.56% | Upgrade
|
| Operating Margin | 7.03% | 5.75% | 7.43% | 7.22% | 6.29% | 2.19% | Upgrade
|
| Profit Margin | 10.88% | 10.33% | 12.38% | 11.21% | 9.25% | 6.02% | Upgrade
|
| Free Cash Flow Margin | 4.00% | 3.25% | 4.84% | 4.06% | 5.81% | 3.26% | Upgrade
|
| EBITDA | 276.44 | 236.25 | 345.27 | 294.96 | 235.92 | 74.38 | Upgrade
|
| EBITDA Margin | 8.07% | 6.74% | 8.20% | 8.10% | 7.15% | 3.03% | Upgrade
|
| D&A For EBITDA | 35.5 | 34.83 | 32.15 | 32.19 | 28.47 | 20.7 | Upgrade
|
| EBIT | 240.95 | 201.42 | 313.12 | 262.77 | 207.46 | 53.69 | Upgrade
|
| EBIT Margin | 7.03% | 5.75% | 7.43% | 7.22% | 6.29% | 2.19% | Upgrade
|
| Effective Tax Rate | 7.47% | 6.33% | 8.38% | 7.29% | 10.40% | 5.66% | Upgrade
|
| Revenue as Reported | - | - | 4,213 | 3,641 | 3,299 | 2,456 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.